Catalyst Award In Diabetes, Endocrinology and Metabolic Diseases (DP1 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The Catalyst Award in Diabetes, Endocrinology and Metabolic Diseases (Catalyst-DEMD) is designed to complement NIDDK's traditional, investigator-initiated grant programs by supporting individual scientists who propose pioneering and transformational studies in DEMD topic areas. Applications should be focused on major scientific challenges, and have the potential to produce an unusually high impact on diseases and conditions that are central to the mission of NIDDK's Division of Diabetes, Endocrinology and Metabolic Diseases. To be considered responsive to this initiative, the proposed research should reflect new and novel scientific directions that are distinct from concepts and approaches being pursued in the investigator’s research program or elsewhere.


  • Letter of Intent Due Date(s): November 3, 2019
  • Application Due Date(s): December 3, 2019

​RFA-DK-19-014 Expiration Date December 04, 2019

Agency Website

Eligibility Requirements

NOTE: Only single PD/PI applications are allowed. Applications with multiple PD(s)/PI(s) will not be accepted.



Amount Description

Awards will be for $500,000 Direct Costs per year, exclusive of subcontract F&A.

The maximum project period is 5 years. 

Funding Type





Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

December 3, 2019